| Literature DB >> 30377420 |
José Aderval Aragão1,2, Rosely Mota Santos1, Osmar Max Gonçalves Neves1, Iapunira Catarina Sant'Anna Aragão3, Felipe Matheus Sant'Anna Aragão3, Maria Izabel Aragão Mota2, Rebeca de Souza Mariano Bastos2, Francisco Prado Reis2.
Abstract
BACKGROUND: Vascular diseases have a direct influence on quality of life (QoL) and directly affect patients' biopsychosocial aspects. Quality of life is therefore an important element for evaluation of vascular interventions.Entities:
Keywords: chronic disease: peripheral arterial disease; quality of life; vascular diseases
Year: 2018 PMID: 30377420 PMCID: PMC6205703 DOI: 10.1590/1677-5449.009017
Source DB: PubMed Journal: J Vasc Bras ISSN: 1677-5449
Socioeconomic characteristics.
|
|
|
|---|---|
|
| |
| Female | 58 (45.7%) |
| Male | 69 (54.3%) |
|
| |
| State capital | 44 (34.6%) |
| Upstate | 83 (65.4%) |
|
| |
| Has partner | 65 (51.2%) |
| Single | 62 (48.8%) |
|
| |
| Catholic | 110 (86.6%) |
| Protestant | 17 (13.4%) |
|
| |
| Illiterate | 33 (26%) |
| Primary education | 81 (63.8%) |
| Secondary education or higher | 13 (10.2%) |
|
| |
| Working | 25 (19.7%) |
| Retired | 102 (80.3%) |
|
| |
| 0 to 1 times minimum wage | 93 (73.2%) |
| 2 times minimum wage or greater | 34 (26.8%) |
Prevalent associated comorbidities and most common medications used.
|
|
|
|---|---|
|
| 99 (78.0%) |
| Angiotensin-converting enzyme inhibitors | 53 (41.7%) |
| Angiotensin II receptor blockers | 58 (45.7%) |
| Diuretics | 18 (14.2%) |
| Calcium channel blockers | 10 (7.9%) |
| Beta blockers | 9 (7.1%) |
| Alpha 2-agonists | 3 (2.4%) |
|
| 27 (21.4%) |
| Metformin | 42 (33.1%) |
| Sulfonylurea | 51 (40.2%) |
| NPH Insulin | 3 (2.4%) |
| DPP4 inhibitor (vildagliptin) | 3 (3.1%) |
QoL Scores.
|
|
|
|
|
|
|---|---|---|---|---|
| Physical | 64.2±27.9 | 35.0±15.3 | 29.2±12.6 | 0.024 |
| Psychological | 113.2±27.4 | 59.8±13.5 | 53.4±13.9 | 0.015 |
| Social relationships | 150.2±28.9 | 74.9±15.3 | 75.3±13.6 | 0.873 |
| Environment | 97.2±20.3 | 50.8±10.8 | 46.4±9.5 | 0.020 |
| Total QoL | 97.9±20.4 | 51.1±10.3 | 46.8±10.1 | 0.039 |
SD: standard deviation; QoL: quality of life.
Características socioeconômicas.
|
|
|
|---|---|
|
| |
| Feminino | 58 (45,7%) |
| Masculino | 69 (54,3%) |
|
| |
| Capital | 44 (34,6%) |
| Interior | 83 (65,4%) |
|
| |
| Com companheiro(a) | 65 (51,2%) |
| Sem companheiro(a) | 62 (48,8%) |
|
| |
| Católico | 110 (86,6%) |
| Evangélico | 17 (13,4%) |
|
| |
| Analfabeto | 33 (26%) |
| Fundamental – 1º grau | 81 (63,8%) |
| Ensino médio – 2º grau ou mais | 13 (10,2%) |
|
| |
| Empregado | 25 (19,7%) |
| Aposentado | 102 (80,3%) |
|
| |
| De 0 a 1 SM | 93 (73,2%) |
| 2 ou mais SM | 34 (26,8%) |
SM: salário mínimo.
Comorbidades associadas prevalentes e medicamentos mais utilizados.
|
|
|
|---|---|
|
| 99 (78,0%) |
| Inibidores da enzima conversora da angiotensina | 53 (41,7%) |
| Bloqueadores do receptor da angiotensina II | 58 (45,7%) |
| Diurético | 18 (14,2%) |
| Bloqueador de canais de cálcio | 10 (7,9%) |
| Betabloqueador | 9 (7,1%) |
| Alfa 2-agonista | 3 (2,4%) |
|
| 27 (21,4%) |
| Metformina | 42 (33,1%) |
| Sulfoniureia | 51 (40,2%) |
| Insulina NPH | 3 (2,4%) |
| Inibidor de DPP4 (vildagliptina) | 3 (3,1%) |
Escores de QV.
|
|
|
|
|
|
|---|---|---|---|---|
| Físico | 64,2±27,9 | 35,0±15,3 | 29,2±12,6 | 0,024 |
| Psicológico | 113,2±27,4 | 59,8±13,5 | 53,4±13,9 | 0,015 |
| Relações sociais | 150,2±28,9 | 74,9±15,3 | 75,3±13,6 | 0,873 |
| Meio ambiente | 97,2±20,3 | 50,8±10,8 | 46,4±9,5 | 0,020 |
| QV total | 97,9±20,4 | 51,1±10,3 | 46,8±10,1 | 0,039 |
DP: desvio padrão; QV: qualidade de vida.